Application

19340689 · USE OF CASEINOLYTIC PROTEASE P FUNCTION AS A BIOMARKER OF DRUG RESPONSE TO IMIPRIDONE-LIKE AGENTS

Filed 2025-09-25 · Granted · Patent 12692267 (2026-07-28) The official file ↗The patent and its PDF ↗ · Art unit 1691 · Examiner Niloofar Rahmani Easy · CPC C07D 471/14 · Madera Therapeutics, LLC · Lewis Kohn & Walker LLP

Office actions

first was Notice of allowance

RCEs

no appeal

To first action

6.2 mo

to disposition 10.1 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.